THE TOXICITY OF DAILY INHALED AMPHOTERICIN-B

被引：38

作者：

GRYN, J ^{[1
]}

GOLDBERG, J ^{[1
]}

JOHNSON, E ^{[1
]}

SIEGEL, J ^{[1
]}

INZERILLO, J ^{[1
]}

机构：

[1] COOPER UNIV MED CTR, ROBERT WOOD JOHNSON SCH MED, DEPT MED, CAMDEN, NJ USA

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1993年 / 16卷 / 01期

关键词：

FUNGAL PNEUMONIA; AMPHOTERICIN-B; INHALATION THERAPY; NEUTROPENIA;

D O I：

10.1097/00000421-199302000-00011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Inhaled amphotericin was administered to 29 patients with prolonged neutropenia and toxicity was analyzed. Treatment consisted of 30 mg of amphotericin B administered by nebulizer once daily via either a hand-held nebulizer or face mask. The mean duration of treatment was 16 days. Toxicity was minimal and patient had significant toxic reaction to the inhaled medication. This study documents that nebulized amphotericin B has less than 10% incidence of severe toxicity with 95% confidence level. Guidelines for future trials and use are suggested.

引用

页码：43 / 46

页数：4

共 50 条

[21] REDUCED TOXICITY OF AMPHOTERICIN-B METHYL-ESTER (AME) VS AMPHOTERICIN-B AND FUNGIZONE IN TISSUE-CULTURE
FISHER, PB
GOLDSTEIN, NI
BRYSON, V
SCHAFFNER, CP
IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1976, 12 (02): : 133 - 140
[22] Amphotericin-B/amphotericin-B liposomal/voriconazoleVarious toxicities: case report
Reactions Weekly, 2016, 1583 (1) : 85 - 85
[23] Amphotericin-B/amphotericin-B liposomal/immunosuppressantsVarious toxicities: case report
Reactions Weekly, 2019, 1749 (1) : 42 - 42
[24] REDUCED RENAL TOXICITY AND IMPROVED CLINICAL TOLERANCE OF AMPHOTERICIN-B MIXED WITH INTRALIPID COMPARED WITH CONVENTIONAL AMPHOTERICIN-B IN NEUTROPENIC PATIENTS
MOREAU, P
MILPIED, N
FAYETTE, N
RAMEE, JF
HAROUSSEAU, JL
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 (04) : 535 - 541
[25] STABILITY STUDIES WITH AMPHOTERICIN-B AND AMPHOTERICIN-B METHYL-ESTER
BONNER, DP
MECHLINSKI, W
SCHAFFNER, CP
JOURNAL OF ANTIBIOTICS, 1975, 28 (02): : 132 - 135
[26] DISPOSITION AND TOXICITY OF AMPHOTERICIN-B IN THE HYPERLIPIDEMIC ZUCKER RAT MODEL
VADIEI, K
LOPEZBERESTEIN, G
LUKE, DR
INTERNATIONAL JOURNAL OF OBESITY, 1990, 14 (06) : 465 - 472
[27] TREATMENT OF MYCOTIC INFECTIONS - HYDROCORTISONE IN THE CONTROL OF AMPHOTERICIN-B TOXICITY
SALIBA, A
BEATTY, OA
DISEASES OF THE CHEST, 1962, 41 (02): : 214 - 219
[28] EFFECTS OF THE AGGREGATION STATE OF AMPHOTERICIN-B ON ITS TOXICITY TO MICE
BARWICZ, J
CHRISTIAN, S
GRUDA, I
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) : 2310 - 2315
[29] TOXICITY AND PHARMACOKINETICS OF SUBCONJUNCTIVAL AMPHOTERICIN-B - AN EXPERIMENTAL-STUDY
ODAY, DM
SMITH, R
STEVENS, JB
WILLIAMS, TE
ROBINSON, RD
HEAD, WS
CORNEA, 1991, 10 (05) : 411 - 417
[30] UNUSUAL LIPID STRUCTURES SELECTIVELY REDUCE THE TOXICITY OF AMPHOTERICIN-B
JANOFF, AS
BONI, LT
POPESCU, MC
MINCHEY, SR
CULLIS, PR
MADDEN, TD
TARASCHI, T
GRUNER, SM
SHYAMSUNDER, E
TATE, MW
MENDELSOHN, R
BONNER, D
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) : 6122 - 6126

← 1 2 3 4 5 →